Last reviewed · How we verify
NCT06311019: Dia2tech
The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections
NA trial testing Continuous glucose monitoring and use of connected insulinpen for bolus insulin in Type 2 Diabetes Treated With Insulin in 104 participants. Participants enrolled and being followed up; not accepting new ones.
1 July 2025
Quick facts
| Lead sponsor | Klavs Würgler Hansen |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 104 |
| Start date | 27 February 2024 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 5 locations across Denmark |
Drugs / interventions tested
- Continuous glucose monitoring and use of connected insulinpen for bolus insulin
Conditions studied
- Type 2 Diabetes Treated With Insulin — all drugs for Type 2 Diabetes Treated With Insulin →
Sponsor
Klavs Würgler Hansen
Who can join
Adults 18 to 80, any sex, with Type 2 Diabetes Treated With Insulin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the effect of a combination of 12 months treatment with CGM (Freestyle Libre 2) with hypo and hyper alert in combination with a smart pen for bolus insulin (NOVOpen6) on HbA1c and time in range (TIR) in T2DM patients with baseline HbA1c \>53 mmol/mol (7. 0%, eAG 8,6 mmol/l) as compared with standard care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06311019
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type 2 Diabetes Treated With Insulin
Currently open trials in the same condition.
- NCT07063420 — Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers · NA · recruiting
- NCT05317585 — Continuous Glucose Monitor Use in Pregnancy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06311019 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Klavs Würgler Hansen
- Last refreshed: 7 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06311019.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing